Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Brixton Metals Drills 5,791 g/t Silver Over 1.75m within 14.45m of 721.4 g/t Silver And 15,522 g/t Silver Over 0.5m within 14.35m of 708.7 g/t at its Langis Silver Project
-
Fairfax Agrees to Sell a Portion of Its Interest in Poseidon Corp.
-
GURU Organic Energy Boosts the Season with New GURU Zero Orange Raspberry Sorbet
-
Momus Analytics and CTO Jorge Fonte Featured in CIO Applications for Advancing Data-Driven Jury Intelligence
-
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
-
Telesat advances Telesat Lightspeed terrestrial network with new Quebec and Saskatchewan landing station sites
-
IQ.AI by FTI Technology Achieves Measurable Results Globally for World’s Largest In-House Legal Teams and Law Firms, Adds IQ.AI Studio
-
Kelly Appoints Joel Leege as President of Kelly Science, Engineering, Technology & Telecom (SETT)
-
Sisters Rising Worldwide Launches Public PeaceRoom Platform to Amplify and Fund Sister-Led Solutions to Poverty and Injustice
-
EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference
-
Oil could hit $150/bbl as Gulf shutdown of 15 million b/d forces demand destruction
-
Kane Biotech Expands U.S. Commercial Footprint with Strategic Distribution Partnership
-
Hirevue Acquires Hireguide Technology to Accelerate Agentic AI Hiring
-
WestKam Gold Corp. Announces Name Change to Big Bear Gold Corp. and New Symbol “BEAR”
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - LondonMetric Property Plc
-
Man Group PLC : Form 8.3 - Bluefield Solar Income Fund Ltd
-
Man Group PLC : Form 8.3 - Beazley Plc
-
NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant in Charcot-Marie-Tooth d
-
NMD Pharma late breaking oral presentation at the MDA Conference with top-line safety and efficacy data from SYNAPSE-CMT, an exploratory Phase 2a clinical study of ignaseclant in Charcot-Marie-Tooth d
-
Port Administration of American Samoa and ATLAS Space Operations Finalize Agreement for New Satellite Ground Station
-
Nearly 2 in 3 Americans Left Super Bowl LX Curious About Spanish or Latin Culture, New Superprof Survey Finds
-
Willis Lease Finance Corporation Reports Record 2025 Financial Results
-
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
-
KVH Industries Reports Fourth Quarter and Full Year 2025 Results
-
Stallion Uranium Announces Completion of Airborne VTEM Survey Over Stone Island, Provides Coyote Drilling Update
-
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
-
925SilverJewelry by Phoenix Manufacturing Announces New Sterling Silver Collections Amid Rising Global Silver Prices
-
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
-
Prelude Therapeutics Reports Full Year 2025 Financial Results and Provides Program Outlook for 2026
-
Ultralife Corporation Reports Fourth Quarter Results
-
HeyNews Launches AdApt to Rewrite Sponsor Ad Copy in Newsletter Publishers' Own Voice
-
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
-
Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
-
eGain Announces New Integrations for Microsoft Teams, Slack, and Zoom Team Chat
-
Guardian Capital LP Expands Lineup with New Series Launches
-
Kelli Christina Announces Pre-Order Campaign for In Good Faith: A Whistleblower’s War Against a Broken System
-
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, t
-
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Lahontan Gold Appoints Antony Rowe and Miranda Werstiuk to the Board of Directors
-
ABOOT STUDIOS LAUNCHES VIRTUAL DANCE SPACE TO BRING CONNECTION, CREATIVITY AND FREEDOM TO HOSPITALIZED CHILDREN
-
Xanadu and AMD Accelerate Quantum Computing for Aerospace and Engineering
-
AAFA’s 2026 Allergy Capitals Report Highlights Climate and Health Emergency
-
Inspired Reports Fourth Quarter And Full Year 2025 Results
-
Eledon Pharmaceuticals Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Liver Transplantation
-
Amplify ETFs Launches Amplify Municipal CEF High Income ETF (YYYM)
-
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
Vireo Growth Inc. to Release Fourth Quarter and Full Year 2025 Results on March 17, 2026
-
Rapport Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
